scorecardresearch
Saturday, May 4, 2024
TopicCovid vaccine

Topic: Covid vaccine

Modi govt plans Rs 50,000 cr credit incentives scheme to boost health infrastructure

With a likely focus on smaller towns, the initiative will allow companies to access funds for ramping up hospital capacity or medical supplies, with govt acting as a guarantor.

Haj committee cancels applications of Indian pilgrims after Saudi bans entry to non-residents

This is the second consecutive year when Indians will miss going for the annual pilgrimage, owing to travel restrictions that have been put in place because of the Covid pandemic.

Covaxin supply price to Centre at Rs 150/dose not sustainable in long run: Bharat Biotech

Bharat Biotech said reasons such as low procurement volumes, high distribution costs and retail margins among others contribute to the higher pricing of Covaxin.

Why Novavax, a vaccine the world badly needs, is looking better than ever

Novavax Monday announced that its vaccine was 90.4 per cent effective in preventing mild and moderate Covid in a large trial in the US and Mexico and prevented all severe disease.

G7 focus on China a breather for Modi’s India. But questions on Covid drugs won’t go away

G7 diplomats are now echoing the Supreme Court of India — why hasn't the Modi govt granted compulsory licences to pharma companies to at least manufacture anti-Covid drugs if not vaccines.

Superstition keeps Bengal tribals off Covid test & vaccine, govt says ‘can’t drag people out’

Lack of awareness & poor healthcare facilities add to fear of treatment & superstition among tribal villagers, making it a challenge for the Bengal govt to handle the Covid crisis in these villages.

Novavax vaccine has 90% efficacy, protects against Covid variants, finds study

Novavax's study involved nearly 30,000 people aged 18 and up in the US and Mexico. Two-thirds received two doses of the vaccine 3 weeks apart, and the rest got dummy shots.

Bharat Biotech promised shot cheaper than bottled water. But Covaxin is 3rd costliest in world

Experts are divided on whether manufacturer Bharat Biotech is profiteering or is unable to recover investment costs of the made-in-India vaccine.

Covid-19 pandemic: 4th wave fear in Pakistan’s Sindh, Haiti cases rise with no vaccinations

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

China approves emergency use of two Covid vaccines for kids aged 3-17

Chinese Center for Disease Control and Prevention says expanded clinical trials found the two vaccines were safe and capable of stimulating strong immune response among children.

On Camera

Prajwal Revanna case shows why and how sexual crimes by men in politics can go unchecked for years

It would be a disservice to the women of Hassan to look at Prajwal Revanna’s alleged abuse of power as a ‘sex scandal’. Allegations against him show what ‘absolute power corrupts absolutely’ actually means.

Air India reduces baggage allowance by 5-15 kg, bringing it in line with rest of industry

Air India’s new policy, effective from 2 May, introduces new weight limits for tickets in each of the different 'fare families' — Comfort, Comfort Plus, and Flex.

China builds road through Shaksgam Valley, India registers protest

New Delhi has, in past, too, objected to Chinese construction activities in Shaksgam Valley. Work in this strategic region gathered pace after the 2017 Doklam stand-off.

Frontrunner is letting the challenger define this poll campaign. Modi still hasn’t found a big theme

A theme has not yet emerged for BJP & people see lack of a contest, which makes it unexciting. For all these reasons, 2024 is turning out to be an unexpectedly theme-less election.